Home › Brain Tumors › Utah
Brain Tumors clinical trials in Utah
8 studies for Brain Tumors are looking for participants at sites in Utah.
Cities in Utah
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
- Huntsman Cancer Institute, University of Utah, Salt Lake City
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07326566A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
- Huntsman Cancer Institute/University of Utah, Salt Lake City
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT04511013Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma
- Primary Children's Hospital, Salt Lake City
RecruitingPhase 2
59 Months · All sexes · Updated Sep 15, 2026 · NCT05535166A Phase 1/1b Study of IAM1363 in HER2 Cancers
- START Mountain Region, West Valley City
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT06253871Stereotactic Radiosurgery Dose Escalation for Brain Metastases
- Huntsman Cancer Institute, Salt Lake City
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jul 2, 2026 · NCT02390518Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
- University of Utah, Huntsman Cancer Institute, Salt Lake City
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Apr 13, 2026 · NCT06810544Guided Meditation During Radiation Therapy for Brain Tumors
- Huntsman Cancer Institute, Salt Lake City
Recruiting
Ages 18 and older · All sexes · Updated Mar 20, 2026 · NCT06165653Defactinib and Avutometinib, With or Without Encorafenib, for the Treatment of Patients With Brain Metastases From Cutaneous Melanoma
- Huntsman Cancer Institute, Salt Lake City
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Dec 3, 2025 · NCT06194929From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.